Navigation Links
Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Date:10/14/2008

nvestors in Regado include Domain (Princeton, NJ), Quaker BioVentures (Philadelphia, PA), Aurora Funds (Durham, NC) and Caxton Advantage Life Sciences Fund (New York, NY), as well as individual investors, including Robert Kierlin.


'/>"/>
SOURCE Regado Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
5. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
6. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
7. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
8. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
11. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014  Researchers from the North American ... elevates calcium levels too high, 1 putting ... problems. Women close to menopause are commonly ... to prevent diseases such as osteoporosis, to which they ... women determine how much calcium they typically get through ...
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, ... its new headquarters, manufacturing and research facility: ... 80112 Direct: (720) 437-6500 ... efficient, pharmaceutical drug manufacturing facility will be fully operational ... the first batches of Ampion TM necessary to ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... 2011 Assured Pharmacy (Pink Sheets: APHY ), ... than 3,000 sufferers of chronic pain announced that total sales ... 2010 were $1,514,984 which equates to $70,464 per business day. ... total sales of $1,348,344 for December 2009 which equates to ...
... 2011 BioDelivery Sciences International, Inc. ... outcome of a pre-Investigational New Drug (pre-IND) meeting ... on the development program for BEMA Buprenorphine/Naloxone, BDSI,s ... discussed is based on pharmacokinetic and safety data ...
Cached Medicine Technology:Assured Pharmacy Reports Same Store Sales for the Month of December 2010 2Assured Pharmacy Reports Same Store Sales for the Month of December 2010 3BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 2BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting 3
(Date:7/23/2014)... Karen Pallarito HealthDay Reporter ... wild day for Obamacare, two federal appeals courts arrived at ... provided to millions of Americans who bought health insurance through ... the matter is headed for a showdown before the U.S. ... U.S. Appeals Court for the District of Columbia Circuit said ...
(Date:7/23/2014)... The European Vitamins Market report explains ... and projection of revenue. The market in Europe is ... to $1,202.08 million by 2018, at a CAGR of ... TOC of the European Vitamins Market report, to get ... provides a glimpse of the segmentation in the European ...
(Date:7/23/2014)... The European Bio fertilizers Market Report defines ... analysis and forecast of revenue. The bio fertilizers market ... 2,566.4 million in 2012 to $4,582.2 million by 2017, ... , Browse through the TOC of the European Bio ... in-depth analysis provided. , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , ...
(Date:7/23/2014)... Bethesda, MD (July 23, 2014) Statins, a class ... reduce a patient,s risk of developing Barrett,s esophagus, according ... , the official journal of the American ... risk reduction with statin use. , "Patients who received ... of having Barrett,s esophagus compared to non-users," said study ...
(Date:7/23/2014)... July 23, 2014 According to a ... by Form Factor (Integrated Circuit IP, SOC IP), Design ... Application, Geography and Verification IP - Forecast & Analysis ... is expected to grow at a CAGR of 12.6% ... 2020. , Browse more than 76 market data tables ...
Breaking Medicine News(10 mins):Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 2Health News:2 Courts, 2 Different Decisions on Key Obamacare Provision 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6
... a leading provider of laser vision correction services under ... center in Des,Moines, Iowa. This marks the 74th LasikPlus ... vision center in the state of Iowa.,LasikPlus vision centers ... Similar to other LasikPlus vision centers throughout the ...
... Highlights Myriad Opportunities for Using Wireless ... Efficiency and Accuracy of Patient Care, WALTHAM, Mass., ... intelligent wireless LANs (WLANs) for enterprises and,service providers, will ... Exhibition, taking place February 24-28 in Orlando, FL, to,showcase ...
... ECG Devices Help Healthcare Organizations Deliver Clinical ... Data Faster and ... Networks, the leading,global provider of intelligent wireless LANs (WLANs) ... Corporation,(Nasdaq: CSCX ) ( http://www.cardiacscience.com ), the leading ...
... of, CellCept Will Provide Effective Treatment Options, According ... ... Feb. 25 Decision Resources, one of the,world,s leading research ... entry and uptake of high-priced branded,agents will drive the systemic ...
... HealthVault Empowers Patients to Orchestrate Health ... ... the leading provider,of next generation healthcare connectivity solutions, today announced ... using Microsoft(R) HealthVault(TM), at the 2008 HIMSS,(Healthcare Information and Management ...
... Hyperion,Therapeutics, Inc. today announced that the first ... trial of AMMONUL(R) (sodium phenylacetate and sodium,benzoate) Injection ... hepatic,encephalopathy (HE). The randomized, double-blind study is designed ... standard of care in,hospitalized adults. The FDA has ...
Cached Medicine News:Health News:LCA-Vision Announces the Opening of its 74th LasikPlus Vision Center in Des Moines, Iowa 2Health News:Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 2Health News:Cardiac Science Corporation Selects Colubris Networks' Wireless Solution for its Portable Electrocardiograph 3Health News:Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 2Health News:Kryptiq and Microsoft to Showcase Unprecedented Connectivity Between Consumers and Their Doctors at HIMSS '08 3Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 2Health News:Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy 3